Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19 studies found for:    Premenstrual Syndrome: Clinical Trials
Show Display Options
Download search resultsDownload the search results for:
Premenstrual Syndrome: Clinical Trials (19 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS)
Condition: Premenstrual Syndrome
Interventions: Drug: extracts of Vitex agnus castus tablets;   Drug: Placebo
2 Completed Auriculotherapy in the Cares to the Premenstrual Syndrome
Condition: Premenstrual Syndrome
Intervention: Other: Auriculotherapy group
3 Not yet recruiting Homeopathic Treatment of Premenstrual Syndrome
Condition: Premenstrual Syndrome-PMS
Interventions: Drug: Natrum muriaticum 30C;   Drug: Lachesis 30C;   Drug: Sepia 30C;   Drug: Nux vomica 30C;   Drug: Pulsatilla 30C;   Drug: Folliculinum 30C;   Drug: Placebo Natrum muriaticum;   Drug: Placebo Lachesis;   Drug: Placebo Sepia;   Drug: Placebo Nux vomica;   Drug: Placebo pulsatilla;   Drug: Placebo Folliculinum
4 Terminated Efficacy and Safety of 20 mg (2 Tablets of 10mg)VAC BNO 1095 FCT on Cyclic Mastodynia and PMS
Conditions: Premenstrual Syndrome;   Mastodynia
Interventions: Drug: 20mg VAC BNO 1095 FCT;   Drug: Placebo
5 Completed Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome
Condition: Premenstrual Syndrome
Interventions: Drug: Yasmin;   Dietary Supplement: Calver;   Drug: Placebo 1;   Drug: Placebo 2
6 Recruiting Dienogest Versus Luteal Phase Fluoxetine in the Management of Premenstrual Syndrome
Condition: Premenstrual Syndrome
Interventions: Drug: Dienogest;   Drug: Fluoxetine;   Drug: Placebo
7 Recruiting Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome
Condition: Premenstrual Syndrome
Interventions: Drug: Combined oral contraceptives;   Drug: Fluoxetine;   Drug: Combined oral contraceptives placebo;   Drug: Fluoxetine placebo;   Procedure: Daily record of severity of problems
8 Completed Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
Conditions: Premenstrual Syndrome;   Menstruation Disturbances
Intervention: Drug: Levonorgestrel/Ethinyl Estradiol
9 Completed Role of Ginkgo Biloba Extract in IUGR
Condition: Intrauterine Growth Restriction (IUGR)
Interventions: Drug: Ginkgo Biloba Extract;   Other: Placebo
10 Recruiting Effect of Homeopathy, Acupuncture or Anthroposophic Medicine in Women's Quality of Life
Conditions: Anxiety;   Depression;   Premenstrual Tension;   Hot Flashes;   Muscular Diseases
Intervention: Other: World Health Organization Quality of Life Bref Questionnaire
11 Unknown  Impact of Hot Flashes on Sleep and Mood Disturbance
Conditions: Menopause;   Depression;   Hot Flashes
Intervention: Drug: Leuprolide
12 Completed Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment) Of Menstrual Migraine
Condition: Menstrual Migraine (MM) Headaches
Interventions: Drug: Frovatriptan;   Drug: Usual Care
13 Completed Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea
Condition: Migraine Disorders
Interventions: Drug: sumatriptan succinate/naproxen sodium;   Drug: placebo
14 Completed Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder
Condition: Borderline Personality Disorder
Interventions: Drug: Selegiline;   Drug: Placebo (for Selegiline)
15 Unknown  Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.
Conditions: Menstrual Migraines;   Menstrual Bleeding;   Menstrual Spotting
Intervention: Drug: Estradiol or Placebo
16 Completed Luteal Phase Administration of Paroxetine for the Treatment of PMDD
Condition: Premenstrual Dysphoric Disorder
Intervention: Drug: Paroxetine
17 Completed Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD)
Condition: Premenstrual Dysphoric Disorder
Intervention: Drug: Levetiracetam
18 Not yet recruiting Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
Condition: Premenstrual Dysphoric Disorder
Interventions: Drug: PH80;   Drug: Placebo intranasal spray
19 Completed Diindolylmethane in Treating Patients With Abnormal Cervical Cells
Conditions: Cervical Cancer;   Precancerous Condition
Interventions: Drug: oral microencapsulated diindolylmethane;   Genetic: polymerase chain reaction;   Other: cervical Papanicolaou test;   Other: cytology specimen collection procedure;   Procedure: colposcopic biopsy

Study has passed its completion date and status has not been verified in more than two years.